These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 4053531)
21. [Silymarin and various problems of current therapy of chronic liver diseases]. Fassati P; Fassati M Cas Lek Cesk; 1973; 112(28):865-9. PubMed ID: 4720441 [No Abstract] [Full Text] [Related]
22. [Sylimarine in the treatment of chronic hepatitis]. Sawaryn T; Szymoński K; Machalska M Przegl Epidemiol; 1977; 31(4):445-50. PubMed ID: 607279 [No Abstract] [Full Text] [Related]
23. [Alcoholic hepatopathy. Aspects of drug therapy]. Del Dotto M; Neri D G Clin Med; 1982 Apr; 63(4):228-36. PubMed ID: 7128979 [No Abstract] [Full Text] [Related]
24. [Effect of the administration of silymarin on serum lipid levels]. Petronelli A; Roda E; Briganti M; Morselli Labate AM; Barbara L Clin Ter; 1981 Dec; 99(5):471-82. PubMed ID: 7333068 [No Abstract] [Full Text] [Related]
25. Liver cell protection in toxic liver lesion. Fehér J; Cornides A; Pál J; Láng I; Csomós G Acta Physiol Hung; 1989; 73(2-3):285-91. PubMed ID: 2596318 [TBL] [Abstract][Full Text] [Related]
32. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats]. Siegers CP Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529 [No Abstract] [Full Text] [Related]
33. [Therapy of hepatoses. Therapeutic use of Silymarin]. Schopen RD; Lange OK Med Welt; 1970 Apr; 15():691-8. PubMed ID: 5523243 [No Abstract] [Full Text] [Related]
34. [Experimental clinical study with Silimarin in the treatment of diffuse liver diseases of potentially reversible nature]. Güemes Díaz F; Pérez Muñóz C; Sallent Herránz J; Arias Vallejo E Rev Clin Esp; 1974 Feb; 132(3):263-8. PubMed ID: 4841954 [No Abstract] [Full Text] [Related]
35. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)]. Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367 [TBL] [Abstract][Full Text] [Related]
36. [Clinical study of the therapeutic action of silymarin in acute infectious hepatitis in childhood]. Mingrino F; Tosti U; Anania S; Buglioni MC; Viola F Minerva Pediatr; 1979 Mar; 31(6):451-6. PubMed ID: 470888 [No Abstract] [Full Text] [Related]
37. [Therapy of liver diseases using Silymarin (Legalon)]. Milosavljevic Z Ther Ggw; 1973 Jun; 112(6):968 passim. PubMed ID: 4200154 [No Abstract] [Full Text] [Related]
38. [Treatment of Amanita phalloides poisoning with silybin in combination with penicillin and cortisone]. Hofer JF; Egermann G; Mach K; Sommer K Wien Klin Wochenschr; 1983 Apr; 95(7):240-3. PubMed ID: 6880207 [TBL] [Abstract][Full Text] [Related]
39. [A new antidyspeptic in hepato-biliary disorders]. Copelman H Hospital (Rio J); 1969 Apr; 75(4):1463-8. PubMed ID: 5306436 [No Abstract] [Full Text] [Related]
40. Re: Flora et al. Silymarin for the therapy of liver disease. Bode JC Am J Gastroenterol; 1999 Feb; 94(2):545-6. PubMed ID: 10022676 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]